Laura R Marcum, LPN | |
1397 Chaney Pike, Campbellsville, KY 42718-9123 | |
(270) 932-1307 | |
Not Available |
Full Name | Laura R Marcum |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1397 Chaney Pike, Campbellsville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770366569 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 2036050 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laura R Marcum, LPN 1397 Chaney Pike, Campbellsville, KY 42718-9123 Ph: (270) 932-1307 | Laura R Marcum, LPN 1397 Chaney Pike, Campbellsville, KY 42718-9123 Ph: (270) 932-1307 |
News Archive
Angiogenesis is a process of new vessel formation that is activated both in physiological (tissue repair, reproduction, etc.) and pathological (myocardial infarction, diabetic retinopathy, cancer, etc.) conditions.
EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a key patent covering its SerosaFuse fastener and "over the wire" delivery system.
Following today's bipartisan health care summit, NSBA is pleading with lawmakers to move beyond the rhetoric. Small-business owners across the U.S. have been struggling for years with the rising cost of health care, and need Congress to act now. For small businesses, the bottom line is addressing health care costs—not the intentions, not the proposals and most certainly not the debates.
In a symposium session on Monday at the XIX International AIDS Conference in Washington, D.C., politicians and public health experts joined Bill & Melinda Gates Foundation Co-Chair Bill Gates for a discussion about improving effectiveness and efficiency in the HIV/AIDS response, the Washington Post reports.
RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, and Athersys Inc. a leader in regenerative medicine and cell therapy research and development, announced today an agreement under which Athersys will provide RTI access to its Multipotent Adult Progenitor Cell (MAPC) technologies.
› Verified 9 days ago